Related Experiment Video
Updated: Jan 16, 2026
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
Published on: June 18, 2018
Methamphetamine abstainer's "cool" and "hot" prepotent response inhibition
Shu-Ho Chen1, Ming-Hong Hsieh2,3, Chieh-Liang Huang4
1Department of Psychology, Chung-Shan Medical University, Taichung, Taiwan.
Introduction:
Methamphetamine (MA) abuse remains a critical issue in Taiwan, with impaired inhibitory control contributing to relapse. However, limited research has examined deficits in prepotent response inhibition across both "cool" (neutral) and "hot" (drug-related) contexts in MA abstainers. This study aimed to investigate these aspects of inhibitory control using a modified antisaccade task.
Methods:
Twenty-four male MA abstainers and twenty-four healthy controls (HC) completed counterbalanced "cool" and "hot" antisaccade tasks. The "hot" condition used MA-related images as distractor backgrounds, while the "cool" condition featured visually similar neutral images. Prepotent response inhibition was assessed across conditions, and correlations with addiction severity, treatment duration, use history, and days of abstinence were analyzed.
Results:
No significant interaction between group and condition or main effects of group and condition were found. However, in abstainers, prepotent response inhibition in both conditions positively correlated with days of abstinence but not with addiction severity, treatment duration, or use history.
Conclusions:
Findings suggest that prepotent response inhibition is more closely linked to recent abstinence duration than long-term addiction severity or treatment history. Future interventions should target inhibitory control in MA abstainers to reduce relapse risk and improve long-term recovery outcomes.
More Related Videos
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Related Concept Videos
01:28Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:25Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
01:20Desensitization and Tachyphylaxis
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists